2 completed, 2 recruiting, 1 not yet recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Relapsing Fever: new trials by email Literature Review of Relapsing Fever trials Research Report on Relapsing Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders Trisomy 8 Mosaicism, Trisomy 8 Associated Autoinflammatory Disease | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 750 | 2026-11-17 | 2026-11-12 | |
| Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia Borrelia Recurrentis Infection | Recruiting | University Hospital, Strasbourg, France | 25 | 2025-02-19 | 2026-01-13 | |
| Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever administration of single dose of doxycycline - Relapsing Fever, Tick-Borne | Not applicable | Not yet recruiting | Medical Corps, Israel Defense Force | 526 | 2024-08-01 | 2024-03-13 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis | Not applicable | Completed | University Hospital, Geneva | 1927 | 2013-01-01 | 2016-10-27 |
| Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever doxycycline treatment - Relapsing Fever, Tick-borne, Jarisch Herxheimer Reaction | Phase 2 / Phase 3 | Completed | Medical Corps, Israel Defense Force | 140 | 2002-04-01 | 2024-12-19 |
Borrelia Infections (1) · Brucellosis (1) · Chromosome 8, mosaic trisomy (1) · Foot-and-Mouth Disease (1) · Leishmaniasis, Visceral (1) · Leptospirosis (1) · Liver Abscess, Amebic (1) · Malaria (1) · Melioidosis (1) · Myelodysplastic Syndromes (1) · Rickettsia Infections (1) · Tick-Borne Diseases (1) · Tuberculosis (1) · Typhoid Fever (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Gram-Negative Bacterial Infections (5) · Infections (5) · Spirochaetales Infections (5) · Vector Borne Diseases (5) · Borrelia Infections (4) · Tick-Borne Diseases (4) · Abdominal Abscess (1) · Abscess (1) · Actinomycetales Infections (1) · Amebiasis (1) · Animal Diseases (1) · Bone Marrow Diseases (1) · Burkholderia Infections (1)
Doxycycline (1)
Medical Corps, Israel Defense Force (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Hospital, Geneva (1) · University Hospital, Strasbourg, France (1)
Cambodia (1) · Democratic Republic of the Congo (1) · France (1) · Israel (1) · Nepal (1) · Sudan (1) · United States (1)
Barak Gordon, MD (1) · Kalpana Manthiram, M.D. (1) · Tal Hasin, MD (1)